ZEGA Investments LLC purchased a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 64,000 shares of the financial services provider's stock, valued at approximately $6,714,000. Aflac makes up about 1.7% of ZEGA Investments LLC's investment portfolio, making the stock its 11th largest holding.
Other hedge funds and other institutional investors have also modified their holdings of the company. Whipplewood Advisors LLC acquired a new position in shares of Aflac in the fourth quarter valued at approximately $26,000. Darwin Wealth Management LLC purchased a new position in Aflac in the 3rd quarter valued at approximately $34,000. BankPlus Trust Department acquired a new position in shares of Aflac in the fourth quarter worth $34,000. Curio Wealth LLC purchased a new stake in shares of Aflac during the fourth quarter worth $36,000. Finally, Raelipskie Partnership acquired a new stake in shares of Aflac in the third quarter valued at $38,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Aflac Stock Performance
Shares of Aflac stock traded up $0.68 on Wednesday, hitting $110.41. The stock had a trading volume of 1,357,781 shares, compared to its average volume of 1,991,370. The stock has a market cap of $60.35 billion, a price-to-earnings ratio of 11.50, a P/E/G ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 52-week low of $79.31 and a 52-week high of $115.50. The company's 50 day moving average price is $106.21 and its 200 day moving average price is $107.62. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.
Analyst Upgrades and Downgrades
AFL has been the subject of several analyst reports. BMO Capital Markets began coverage on Aflac in a research note on Thursday, January 23rd. They set a "market perform" rating and a $111.00 target price for the company. Barclays cut their target price on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating on the stock in a research note on Friday, February 7th. Piper Sandler decreased their price target on shares of Aflac from $122.00 to $118.00 and set an "overweight" rating for the company in a research note on Friday, February 7th. Evercore ISI dropped their price objective on shares of Aflac from $104.00 to $102.00 and set an "underperform" rating on the stock in a research report on Wednesday, December 4th. Finally, Wells Fargo & Company decreased their price objective on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 19th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, Aflac presently has an average rating of "Hold" and a consensus target price of $103.36.
Read Our Latest Report on AFL
Insider Transactions at Aflac
In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares of the company's stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now directly owns 25,393 shares in the company, valued at $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 55,546 shares of company stock worth $5,863,616. Company insiders own 0.90% of the company's stock.
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
